CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 93 filers reported holding CATALYST BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $121,000 | -19.9% | 23,909 | 0.0% | 0.00% | – |
Q4 2020 | $151,000 | +43.8% | 23,909 | -2.2% | 0.00% | – |
Q3 2020 | $105,000 | -84.8% | 24,443 | -71.2% | 0.00% | -100.0% |
Q1 2019 | $689,000 | -21.3% | 85,008 | -23.4% | 0.00% | 0.0% |
Q4 2018 | $876,000 | -13.4% | 111,004 | +18.4% | 0.00% | 0.0% |
Q3 2018 | $1,011,000 | +273.1% | 93,769 | +303.3% | 0.00% | – |
Q2 2018 | $271,000 | – | 23,250 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 66,951 | $13,859 | 0.01% |
Colorado Capital Management, Inc. | 34,165 | $7 | 0.01% |
Nantahala Capital Management | 160,430 | $33,209 | 0.00% |
Kynam Capital Management, LP | 89,886 | $18,606 | 0.00% |
Keebeck Wealth Management, LLC | 20,000 | $4,140 | 0.00% |
MORGAN STANLEY | 38,404 | $7,950 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 259,467 | $52 | 0.00% |
BlackRock Inc. | 169,904 | $35,170 | 0.00% |
Bank of New York Mellon Corp | 200,638 | $41,532 | 0.00% |
Citadel Advisors | 5,700 | $1,180 | 0.00% |